Literature DB >> 18486506

Chronic whiplash symptoms are related to altered regional cerebral blood flow in the resting state.

Clas Linnman1, Lieuwe Appel, Anne Söderlund, Orjan Frans, Henry Engler, Tomas Furmark, Torsten Gordh, Bengt Långström, Mats Fredrikson.   

Abstract

The neural pathogenic mechanisms involved in mediating chronic pain and whiplash associated disorders (WAD) after rear impact car collisions are largely unknown. This study's first objective was to compare resting state regional cerebral blood flow (rCBF) by means of positron emission tomography with (15)O labelled water in 21 WAD patients with 18 healthy, pain-free controls. A second objective was to investigate the relations between brain areas with altered rCBF to pain experience, somatic symptoms, posttraumatic stress symptoms and personality traits in the patient group. Patients had heightened resting rCBF bilaterally in the posterior parahippocampal and the posterior cingulate gyri, in the right thalamus and the right medial prefrontal gyrus as well as lowered tempero-occipital blood flow compared with healthy controls. The altered rCBF in the patient group was correlated to neck disability ratings. We thus suggest an involvement of the posterior cingulate, parahippocampal and medial prefrontal gyri in WAD and speculate that alterations in the resting state are linked to an increased self-relevant evaluation of pain and stress.

Entities:  

Mesh:

Year:  2008        PMID: 18486506     DOI: 10.1016/j.ejpain.2008.03.001

Source DB:  PubMed          Journal:  Eur J Pain        ISSN: 1090-3801            Impact factor:   3.931


  11 in total

1.  Interrelationships between pain processing, cortisol and cognitive performance in chronic whiplash-associated disorders.

Authors:  Mira Meeus; Jessica Van Oosterwijck; Kelly Ickmans; Isabel Baert; Iris Coppieters; Nathalie Roussel; Filip Struyf; Nathalie Pattyn; Jo Nijs
Journal:  Clin Rheumatol       Date:  2013-12-13       Impact factor: 2.980

2.  The medial temporal lobe in nociception: a meta-analytic and functional connectivity study.

Authors:  Lizbeth J Ayoub; Alexander Barnett; Aziliz Leboucher; Mitchell Golosky; Mary Pat McAndrews; David A Seminowicz; Massieh Moayedi
Journal:  Pain       Date:  2019-06       Impact factor: 6.961

Review 3.  The young brain and concussion: imaging as a biomarker for diagnosis and prognosis.

Authors:  Esteban Toledo; Alyssa Lebel; Lino Becerra; Anna Minster; Clas Linnman; Nasim Maleki; David W Dodick; David Borsook
Journal:  Neurosci Biobehav Rev       Date:  2012-03-28       Impact factor: 8.989

4.  The nosological classification of whiplash-associated disorder: a narrative review.

Authors:  Joe H Ghorayeb
Journal:  J Can Chiropr Assoc       Date:  2021-04

5.  Brain Network Disruption in Whiplash.

Authors:  J P Higgins; J M Elliott; T B Parrish
Journal:  AJNR Am J Neuroradiol       Date:  2020-06-04       Impact factor: 3.825

6.  Advancements in Imaging Technology: Do They (or Will They) Equate to Advancements in Our Knowledge of Recovery in Whiplash?

Authors:  James M Elliott; Sudarshan Dayanidhi; Charles Hazle; Mark A Hoggarth; Jacob McPherson; Cheryl L Sparks; Kenneth A Weber
Journal:  J Orthop Sports Phys Ther       Date:  2016-10       Impact factor: 4.751

Review 7.  Rehabilitation of chronic whiplash: treatment of cervical dysfunctions or chronic pain syndrome?

Authors:  Jo Nijs; Jessica Van Oosterwijck; Willem De Hertogh
Journal:  Clin Rheumatol       Date:  2009-01-22       Impact factor: 2.980

8.  Chronic Whiplash-Associated Disorders: Reorganization of the Brain?

Authors:  Iris Coppieters; Anneleen Malfliet
Journal:  EBioMedicine       Date:  2016-08-09       Impact factor: 8.143

9.  Myofascial-entheseal dysfunction in chronic whiplash injury: an observational study.

Authors:  Qmk Bismil; Msk Bismil
Journal:  JRSM Short Rep       Date:  2012-08-20

10.  Altered Regional Cerebral Blood Flow in Chronic Whiplash Associated Disorders.

Authors:  David Vállez García; Janine Doorduin; Antoon T M Willemsen; Rudi A J O Dierckx; Andreas Otte
Journal:  EBioMedicine       Date:  2016-07-14       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.